MAIA
AMEX
$1.36
MAIA Biotechnology Inc (MAIA)
MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes across various malignancies. Utilizing its proprietary technology platforms, MAIA aims to harness the power of the immune system to create targeted therapies that address critical unmet medical needs in oncology. With a strong development pipeline and a strategic commitment to therapeutic innovation, MAIA is well-positioned to become a prominent participant in the biopharmaceutical sector, capitalizing on emerging growth opportunities within the evolving healthcare landscape.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $12.13 (+795.20%)
Market Cap
$79M
Free Cash Flow Yield
-25.11%
Beta (5Y)
0.79
Price Chart
Valuation
Market Cap$79M
P/B3.04
Profitability
EBITDA-$24M
EPS-$0.63
Financial Health
Free Cash Flow Yield-25.11%
Growth & Risk
Beta (5Y)0.79
Sharpe Ratio0.11